» Articles » PMID: 35449568

Cognitive Dysfunction of Chikungunya Virus Infection in Older Adults

Overview
Specialty Psychiatry
Date 2022 Apr 22
PMID 35449568
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chikungunya fever is a disabling articular disease caused by chikungunya virus (CHIKV). In the past decade it has affected millions of people across America, Africa, Asia, and Europe, turning this infection into a public health concern. The acute phase of chikungunya infection is usually self-limiting, characterized by severe arthralgia, fever, chills, myalgia, headache, and rash. CHIKV neurovirulence is evident and seems to be higher among elders. Considering their susceptibility to cognitive decline and dementia, the aim of our study was to investigate whether CHIKV infection might cause long-term cognitive impairment in aged people.

Methods: A cross-sectional study was conducted with volunteers aged from 60 to 90 who had been affected by chikungunya and also with healthy controls. A structured questionnaire was used to record demographic and clinical data, functional status, and depression. Global cognitive function was assessed through MoCA. A comprehensive neuropsychological battery was performed to assess specific cognitive functions.

Results: Subjective memory complaints were present in 70% of subjects with previous chikungunya. This group had a poorer performance in MoCA ( = 0.000) and specific cognitive tests: Semantic ( = 0.05) and Phonemic Verbal Fluency ( = 0.003), 5-Digit (choice, reading, counting and alternance, = 0.003, = 0.014, = 0.021, and = 0.021, respectively), Stroop test (time, errors and interference, = 0.000, = 0.027 and = 0.015, respectively), and RAVLT (word total session = 0.05). These tests reflect performance on general executive functions, cognitive flexibility, inhibitory control, processing speed, semantic memory and episodic memory.

Conclusion: Our data suggest that CHIKV infection may cause long-term cognitive decline in aged people and might be a risk factor for future dementia in this population.

Citing Articles

Characterization of Change in Cognition Before and After COVID-19 Infection in Essential Workers at Midlife.

Sekendiz Z, Morozova O, Carr M, Fontana A, Mehta N, Ali A Am J Med Open. 2024; 12:100076.

PMID: 39498311 PMC: 11533481. DOI: 10.1016/j.ajmo.2024.100076.


The risk and risk factors of chikungunya virus infection and rheumatological sequelae in a cohort of U.S. Military Health System beneficiaries: Implications for the vaccine era.

Pollett S, Hsieh H, Lu D, Grance M, Richard S, Nowak G PLoS Negl Trop Dis. 2024; 18(8):e0011810.

PMID: 39102422 PMC: 11335156. DOI: 10.1371/journal.pntd.0011810.


Exploring the urban arbovirus landscape in Rio de Janeiro, Brazil: transmission dynamics and patterns of disease spread.

Schuab G, Tosta S, Moreno K, Fonseca V, Santos L, Slavov S Lancet Reg Health Am. 2024; 35:100786.

PMID: 38846808 PMC: 11152967. DOI: 10.1016/j.lana.2024.100786.


Review of dengue, zika and chikungunya infections in nervous system in endemic areas.

Puccioni-Sohler M, Nascimento Soares C, Christo P, de Almeida S Arq Neuropsiquiatr. 2023; 81(12):1112-1124.

PMID: 38157877 PMC: 10756841. DOI: 10.1055/s-0043-1777104.


ASSESSMENT AND CHARACTERIZATION OF COVID-19 RELATED COGNITIVE DECLINE: RESULTS FROM A NATURAL EXPERIMENT.

Sekendiz Z, Clouston S, Morozova O, Carr M, Fontana A, Mehta N medRxiv. 2023; .

PMID: 37986906 PMC: 10659478. DOI: 10.1101/2023.11.06.23298101.


References
1.
Petersen R . Mild Cognitive Impairment. Continuum (Minneap Minn). 2016; 22(2 Dementia):404-18. PMC: 5390929. DOI: 10.1212/CON.0000000000000313. View

2.
Harvey P . Domains of cognition and their assessment
. Dialogues Clin Neurosci. 2019; 21(3):227-237. PMC: 6829170. DOI: 10.31887/DCNS.2019.21.3/pharvey. View

3.
Godaert L, Najioullah F, Bartholet S, Colas S, Yactayo S, Cabie A . Atypical Clinical Presentations of Acute Phase Chikungunya Virus Infection in Older Adults. J Am Geriatr Soc. 2017; 65(11):2510-2515. DOI: 10.1111/jgs.15004. View

4.
Burt F, Chen W, Miner J, Lenschow D, Merits A, Schnettler E . Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017; 17(4):e107-e117. DOI: 10.1016/S1473-3099(16)30385-1. View

5.
Paixao E, Rodrigues L, Costa M, Itaparica M, Barreto F, Gerardin P . Chikungunya chronic disease: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2018; 112(7):301-316. DOI: 10.1093/trstmh/try063. View